Unknown

Dataset Information

0

Developing a high-performance liquid chromatography fast and accurate method for quantification of silibinin.


ABSTRACT: OBJECTIVE:Silibinin is an antioxidant agent and is shown to have anticancer effects in different cancers including lung, breast, colorectal, liver, prostate, and kidney. There are challenges in the clinical use of silibinin. The main limitation is low solubility, poor oral absorption, and extensive hepatic metabolism. We aim to develop a High-Performance Liquid Chromatography (HPLC) sensitive method for quantification of silibinin in aqueous samples to quantify its concentration in new formulations. A reverse-phase high-performance liquid chromatography (RP-HPLC) composed of C18 column as stationary phase and the mixture of methanol (90%) and water (10%) as mobile phase. The developed method was validated based on the established guidelines. RESULTS:The retention time for silibinin was seen in 2.97 min after injection. The calibration curve was drawn and the established method demonstrated a linear ranged from 10 to 100 µg/ml, with a correlation coefficient of 0.996. The sensitivity of the developed method was 10 µg/ml. The accuracy calculated in the range of 88-105.9% and the precision (as relative standard deviation) was between 2.7 and 10.9%. These results demonstrate that the developed method can be a fast and accurate method for quantification of silibinin in aqueous samples.

SUBMITTER: Bakhshi F 

PROVIDER: S-EPMC6854794 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Developing a high-performance liquid chromatography fast and accurate method for quantification of silibinin.

Bakhshi Faezeh F   Molavi Ommoleila O   Rashidi Mohammad Reza MR   Shayanfar Ali A   Amini Hassan H  

BMC research notes 20191114 1


<h4>Objective</h4>Silibinin is an antioxidant agent and is shown to have anticancer effects in different cancers including lung, breast, colorectal, liver, prostate, and kidney. There are challenges in the clinical use of silibinin. The main limitation is low solubility, poor oral absorption, and extensive hepatic metabolism. We aim to develop a High-Performance Liquid Chromatography (HPLC) sensitive method for quantification of silibinin in aqueous samples to quantify its concentration in new f  ...[more]

Similar Datasets

| S-EPMC4983383 | biostudies-literature
| S-EPMC6648825 | biostudies-literature
| S-EPMC1154125 | biostudies-other